Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Diabetes Mellitus · Hemophilia A

Takeda

Takeda clinical programs — 393 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Cambridge, USA HQ
1993 Founded
1,617 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Cambridge, USA
Founded
1993
Employees
1,617
Programs
1179
Drugs
359
Patents
1436
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Takeda projects

393 ClinicalTrials.gov programs sponsored by Takeda.

Takeda has 393 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

393 programs

Clinical programs

Page 1 of 9

  1. 040201

    Takeda

    Hemophilia A

    phase 3 small molecule completed

    1 trial

  2. 060103

    Takeda

    Hemophilia A

    phase 3 mab completed

    1 trial

  3. 060401

    Takeda

    Hemophilia A

    phase 3 small molecule completed

    1 trial

  4. 061002

    Takeda

    Hemophilia A

    phase 3 mab terminated

    1 trial

  5. 090701

    Takeda

    Hemophilia A or B With Inhibitors

    phase 3 mab completed

    1 trial

  6. 160701

    Takeda

    Alzheimer´s Disease

    phase 3 mab completed

    1 trial

  7. 160902

    Takeda

    Primary Immunodeficiency Diseases (PID)

    phase 3 mab completed

    1 trial

  8. 161003

    Takeda

    Alzheimer´s Disease

    phase 3 mab terminated

    1 trial

  9. 161202

    Takeda

    Alzheimer´s Disease

    phase 3 small molecule terminated

    1 trial

  10. 170904

    Takeda

    Primary Immunodeficiency Diseases (PID)

    phase 3 mab completed

    1 trial

  11. 241502

    Takeda

    Hemophilia A

    phase 3 mab terminated

    1 trial

  12. 25 mg Ontamalimab

    Takeda

    Crohn's Disease

    phase 3 small molecule completed

    1 trial

  13. 9vHPV Vaccine

    Takeda

    Dengue Fever

    phase 3 mab completed

    1 trial

  14. ALX1-11

    Takeda

    Osteoporosis

    phase 3 small molecule completed

    1 trial

  15. ALX1-11 (drug)

    Takeda

    Osteoporosis

    phase 3 small molecule completed

    1 trial

  16. AMG 479

    Takeda

    Adenocarcinoma of the Pancreas

    phase 3 small molecule completed

    1 trial

  17. AMG 706

    Takeda

    Non-Small Cell Lung Cancer

    phase 3 small molecule terminated

    1 trial

  18. ARALAST NP 60 mg/kg

    Takeda

    Chronic Obstructive Pulmonary Disease

    phase 3 mab terminated

    1 trial

  19. ASCs (Cx401, company code)

    Takeda

    Anal Fistula

    phase 3 small molecule completed

    1 trial

  20. Actovegin

    Takeda

    Post-Stroke Cognitive Impairment (PSCI)

    phase 3 small molecule completed

    1 trial

  21. Actovegin

    Takeda

    Peripheral Arterial Diseases

    phase 3 small molecule completed

    1 trial

  22. Adynovate

    Takeda

    Hemophilia A

    phase 3 mab completed

    1 trial

  23. Alisertib

    Takeda

    Relapsed Peripheral T-Cell Lymphoma

    phase 3 small molecule completed

    1 trial

  24. Alogliptin

    Takeda

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    5 trials

  25. Alogliptin

    Takeda

    Diabetes Mellitus

    phase 3 small molecule completed

    9 trials

  26. Alogliptin Benzoate

    Takeda

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    1 trial

  27. Alogliptin and glimepiride

    Takeda

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  28. Alogliptin and glyburide

    Takeda

    Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  29. Alogliptin and insulin

    Takeda

    Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  30. Alogliptin and metformin

    Takeda

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  31. Alogliptin and metformin

    Takeda

    Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  32. Alogliptin and pioglitazone

    Takeda

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  33. Alogliptin and pioglitazone

    Takeda

    Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  34. Alogliptin and voglibose

    Takeda

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  35. Amlodipine

    Takeda

    Hypertension

    phase 3 small molecule terminated

    1 trial

  36. Anagrelide Hydrochloride

    Takeda

    Essential Thrombocythemia (ET)

    phase 3 small molecule completed

    1 trial

  37. Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg

    Takeda

    Major Depressive Disorder

    phase 3 small molecule completed

    3 trials

  38. Azacitidine

    Takeda

    Myelodysplastic Syndrome

    phase 3 small molecule completed

    1 trial

  39. Azilsartan

    Takeda

    Pediatric Hypertension

    phase 3 small molecule completed

    2 trials

  40. Azilsartan Medoxomil

    Takeda

    Hypertension

    phase 3 small molecule completed

    7 trials

  41. Azilsartan Medoxomil and amlodipine

    Takeda

    Hypertension

    phase 3 small molecule completed

    1 trial

  42. Azilsartan medoxomil and chlorthalidone

    Takeda

    Essential Hypertension

    phase 3 small molecule completed

    4 trials

  43. Azilsartan medoxomil and chlorthalidone

    Takeda

    Safety

    phase 3 small molecule completed

    1 trial

  44. Azilsartan medoxomil and chlorthalidone

    Takeda

    Hypertension

    phase 3 small molecule completed

    2 trials

  45. Azilsartan medoxomil and olmesartan

    Takeda

    Hypertension

    phase 3 small molecule completed

    1 trial

  46. Azilsartan medoxomil with or without add-on chlorthalidone

    Takeda

    Hypertension

    phase 3 small molecule completed

    1 trial

  47. Azilsartan medoxomil/placebo

    Takeda

    Essential Hypertension

    phase 3 small molecule completed

    1 trial

  48. BAX 326

    Takeda

    Hemophilia B

    phase 3 mab completed

    1 trial

Frequently asked questions

How many clinical projects does Takeda have?

393 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.